Indonesia vs Papua New Guinea: Statin use vs average non hdl cholesterol levels
Indonesia
3.6
in 2018
Papua New Guinea
3.6
in 2018
Indonesia rank
30th
Papua New Guinea rank
30th
Statin use vs average non hdl cholesterol levels over time
- Indonesia
- Papua New Guinea
How they compare
Indonesia currently reports 3.6 against 3.6 in Papua New Guinea, a difference of 0.
Across all 39 years both countries report, Papua New Guinea has been ahead every year.
Indonesia ranks 30th and Papua New Guinea ranks 30th of 191 countries.
Papua New Guinea has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Indonesia | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.9 | 3.33 | 0.43 | Papua New Guinea |
| 1990s | 2.93 | 3.48 | 0.55 | Papua New Guinea |
| 2000s | 3.15 | 3.54 | 0.39 | Papua New Guinea |
| 2010s | 3.5 | 3.6 | 0.1 | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs average non hdl cholesterol levels, Indonesia or Papua New Guinea?
- Indonesia, at 3.6 against 3.6 in Papua New Guinea as of 2018.
- What is the difference in statin use vs average non hdl cholesterol levels between Indonesia and Papua New Guinea?
- 0, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Papua New Guinea?
- 39 years are reported by both, from 1980 to 2018.
- How do Indonesia and Papua New Guinea rank globally for statin use vs average non hdl cholesterol levels?
- Indonesia ranks 30th and Papua New Guinea ranks 30th of 191 countries.
- Where does this data come from?
- Our World in Data, published as Statin use vs average non hdl cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.